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Abstract
Introduction: The role of inhibitory control in addictive behaviors is highlighted in several models of addictive behaviors.
Although reduced inhibitory control has been observed in addictive behaviors, it is inconclusive whether this is evident in
smokers. Furthermore, it has been proposed that drug abuse individuals with poor response inhibition may experience
greater difficulties not consuming substances in the presence of drug cues. The major aim of the current study was to
provide electrophysiological evidence for reduced inhibitory control in smokers and to investigate whether this is more
pronounced during smoking cue exposure.
Methods: Participants (19 smokers and 20 non-smoking controls) performed a smoking Go/NoGo task. Behavioral accuracy
and amplitudes of the N2 and P3 event-related potential (ERP), both reflecting aspects of response inhibition, were the main
variables of interest.
Results: Reduced NoGo N2 amplitudes in smokers relative to controls were accompanied by decreased task performance,
whereas no differences between groups were found in P3 amplitudes. This was found to represent a general lack of
inhibition in smokers, and not dependent on the presence of smoking cues.
Conclusions: The current results suggest that smokers have difficulties with response inhibition, which is an important
finding that eventually can be implemented in smoking cessation programs. More research is needed to clarify the exact
role of cue exposure on response inhibition.
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Introduction
Several contemporary models of addiction highlight the role of
impulsivity and executive functioning in the development and
maintenance of addiction [1–8]. A core component of executive
functioning is response inhibition which is generally defined as the
ability to adaptively suppress behavior when environmental
contingences demand this [9]. It has been proposed that poor
response inhibition in substance-dependent individuals is associ-
ated with difficulties to resist the consumption of a substance
especially when exposed to highly salient substance-related cues
[1].
Reduced response inhibition has been observed in several
substances dependent patient populations including alcohol [10],
cocaine [11], and opioid [12] dependent patients. Some studies
have also investigated response inhibition in smokers. In these
studies, inhibitory control was generally assessed by means of
behavioral paradigms, such as Go/NoGo tasks. In the Go/NoGo
task, participants have to respond as quickly as possible to
frequently occurring ‘Go’ stimuli, and to inhibit responses to
infrequent ‘NoGo’ stimuli. Results of studies on response
inhibition in smokers have been inconsistent. That is, some studies
have found response inhibition during a Go/NoGo task to be
impaired in smokers relative to controls [13] whereas other studies
did not find this group difference in performance on the Go/
NoGo task [14], nor on other behavioral tasks measuring response
inhibition [15,16]. The recording of electroencephalographic
(EEG) activity during response inhibition has been suggested to
yield more sensitive indices (i.e., event-related potentials, ERPs) of
response inhibition and may therefore clarify the inconsistent
results. Two major ERP components have been reported to be
enhanced for NoGo trials as compared to Go trials suggesting that
these reflect changes in brain activity related to response inhibition
in a Go/NoGo task. The first of these ERP-components is the
NoGo N2 which is a negative wave that emerges approximately
200–300 ms after stimulus presentation and has maximum peaks
on frontal scalp sites. Mounting evidence suggests that the NoGo
N2 amplitude is a valuable measure for response inhibition. The
NoGo N2 amplitude has been consistently found to be related to
behavioral outcomes of inhibitory control on Go/NoGo tasks [17]
irrespective of the stimulus modality used in these tasks [18,19].
Although, Go and NoGo trials differ with respect to the overt
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motor response, which could influence the difference between Go
and NoGo N2 amplitudes, it has been found that theNoGo N2 is
not restricted to tasks requiring these overt motor responses [20],
furthermore a modulation of the N2 ERP by response inhibition
requirements has been observed in other inhibition-related
paradigms besides the Go/NoGo task [21–23].
The second ERP component that has been associated with
response inhibition research, is the NoGo P3 which is a positive
wave that emerges circa 300–500 ms after stimulus onset and has
a more central distribution. There are some concerns about the
exact role or meaning of P3 amplitudes in response inhibition
processes [17,24]. In contrast to the NoGo N2, the NoGo P3 does
not seem to be consistently related to response inhibition on a
behavioral level. However, some studies show a clear relationship
between NoGo P3 amplitude and behavioral outcomes of response
inhibition tasks [20,25]. Moreover, because the P3 is a rather late
ERP-component (.300 ms) it has been suggested that it does not
reflect the initial reflexive stage of the inhibition process but rather
a later stage of the inhibition process that is closely related to the
actual inhibition of the motor system in the premotor cortex
[21,26]. In any event, both decreased NoGo P3 and N2
amplitudes have been reported in various populations with
reduced inhibitory control such as children with ADHD [27,28]
and impulsive violent offenders [29] suggesting that both ERP
components are adequate indices of inhibitory processes in
impulsive populations.
Few studies have used ERPs to investigate response inhibition
with ERPs in substance-dependent patients [30–34] and, to our
knowledge, only one of these studies has focused on smokers [33].
Remarkably, with the exception of the study by Yang et al. [32],
analyses of all these studies were confined to the P3 amplitude
whereas studies in other psychiatric populations have usually
investigated both the N2 and P3 amplitudes [27–29,35–40]. ERP
studies investigating response inhibition in substance-dependent
patients have generally found NoGo P3 amplitudes to be reduced
[31,33,34] as compared to healthy controls. However, in heroin
patients only the NoGo N2 amplitude appeared to be reduced; no
differences were found on the NoGo P3 [32].
All the above-mentioned studies investigated general response
inhibition in addicted individuals by using affectively neutral task
paradigms. It has been proposed, however, that the reactivity to
conditioned drug-related stimuli and processes of executive
functioning may impact each other in a synergistic way [1,1,7].
This means that persons with a stronger reactivity towards drug-
related cues may experience more problems with inhibiting their
behavior. Over the course of addiction drug-related stimuli
become extremely attractive to the addicted person and tend to
grab the attention [3,41]. A recent study demonstrated that
participants’ attentional bias for alcohol-related words was
positively correlated with reduced inhibitory control in decision-
making, particularly when the decisions were related to obtaining
alcohol [42]. Altogether, a reciprocal relation between the
attention grabbing properties of drug cues and inhibitory control
has been proposed suggesting that decreased inhibitory control
may be more enhanced during direct exposure to drug-related
stimuli [3].
To test the idea that inhibitory control in substance-dependent
individuals is particularly impaired in the presence of substance-
related cues, the current study investigated response inhibition to
both neutral and smoking-related cues in smokers and non-
smoking controls. For this purpose a novel Go/NoGo paradigm
was developed including smoking and neutral pictures. It is
expected that smokers will generally show reduced response
inhibition as compared to non-smoking controls. More specifically,
on a behavioral level, it is expected that smokers will make more
mistakes when they have to inhibit their response to infrequent
NoGo stimuli. On an electrophysiological level we expect that N2
and P3 amplitudes during NoGo trials will be decreased in
smokers as compared to non-smokers. Finally, we expect these
effects to be more pronounced on trials which include smoking-
related stimuli.
Methods
Participants
Nineteen smokers (mean age = 21.36 years, SD=1.98, 14 male)
and 20 non-smoking controls (mean age= 21.55 years, SD=2.18,
14 male) participated in this study. Exclusion criteria were (a) the
current abuse of a substance (other than nicotine for the smoking
group), and (b) the current presence of a physical or psychiatric
illness. There were no significant differences between the groups in
mean age, t(37) = .27; ns, or gender ratio, x2 (1, n=39) = .07; ns.
Smokers smoked at least 10 cigarettes per day (M=17.95,
SD=5.88; range 10–30) for a duration of at least two years
(M=5.74, SD=3.53, range = 2–17). Fagerstro¨m scores (FTND)
were suggestive of medium levels of nicotine dependence,
M=5.05, SD=2.27, range= 0–8 [43,44]. Non-smokers had
smoked ten or less cigarettes in their lifetime (M=1.22,
SD=2.34, range= 0–10). Participants were undergraduate stu-
dents, who received course credits or a financial compensation for
their participation. The study was conducted in accordance with
the Declaration of Helsinki and all procedures were carried out
with the adequate understanding and written informed consent of
the subjects. The study protocol was approved by the Ethics
Committee of the Institute of Psychology of the Erasmus
University Rotterdam.
Instruments
Breath carbon monoxide concentration was measured using a
Micro+ Smokerlyzer (Bedfort Scientific Ltd., Rochester, UK) in
order to objectively identify smokers and non-smokers. Next to the
FTND, smokers also completed the brief version of the
Questionnaire of Smoking Urges [45] to assess their subjective
craving for a cigarette.
Task paradigm
A smoking-related Go/NoGo task was developed for the aim of
the current study. In this task participants were presented with a
series of pictorial stimuli with a smoking or non-smoking-related
content. Each picture was displayed for 200 ms and had a blue or
yellow frame (see figure 1 for an example of a smoking and non-
smoking trial). The frame color indicated whether a stimulus was a
Go or a NoGo trial. The attribution of the frame color to Go
versus NoGo trials was counterbalanced across participants. Each
stimulus was followed by a black screen for a randomly varying
duration between 1020 ms and 1220 ms. Participants were
instructed to respond to the pictures in Go trials by pressing a
button with the right index finger as fast as possible, and to
withhold their response in the NoGo trials. They were explicitly
instructed to maintain accuracy during the whole task. The task
consisted of 112 different smoking-related pictures and 112 non-
smoking-related pictures. Smoking-related pictures displayed
smoking related objects (e.g., lighter, ashtray etc) or scenes of
people engaged in smoking behavior, whereas non-smoking-
related pictures displayed neutral items or scenes of people
engaged in non-smoking behavior. Each picture was presented for
four times during the whole task, once as a NoGo stimulus and
three times as a Go stimulus. This means that 25% of all trials
Inhibitory Control in Smokers: An ERP Study
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were NoGo trials and that the proportion of smoking and non-
smoking pictures in the task was equal (i.e., 112 NoGo trials per
picture category and 336 Go trials per picture category). The
order of picture content (smoking versus neutral) was completely
randomized and the order of trial type (Go versus NoGo) was
quasi randomized such that at most four Go and two NoGo trials
were presented consecutively. Before the start of the actual task,
participants were given to opportunity to practice in 23 practice
trials, involving additional non-smoking pictures. At four time
moments during the task, participants were given the opportunity
to take a short break. Total task duration was about 22 minutes,
depending on the length of the breaks.
Procedure
Smokers were instructed to abstain from smoking for at least
one hour before the start of the experiment. This short period of
smoking deprivation was introduced in order to reduce the acute
effects of nicotine on ERP amplitudes [46,47] without introducing
withdrawal effects. Participants approved participation by signing
informed consent. The CO breath sample was taken and
questionnaires were completed. Subsequently, participants were
seated in a comfortable EEG chair in a light and sound-attenuated
room. Electrodes were attached and task instructions were
explained. Participants performed the smoking Go/NoGo tasks
during EEG recording. Smokers completed the QSU-brief a
second time at the end of the experiment.
EEG recording and data reduction
The EEG was recorded using the Biosemi Active-Two amplifier
system (Biosemi, Amsterdam, the Netherlands) from 34 scalp sites
(positioned following the 10–20 International System with two
additional electrodes at FCz and CPz) with active Ag/AgCl
electrodes mounted in an elastic cap. Six additional electrodes
were attached to the left and right mastoids, to the two outer
canthi of both eyes (HEOG), and to an infraorbital and a
supraorbital region of the right eye (VEOG). All signals were
digitalized with a sample rate of 512 Hz and 24-bit A/D
conversion with a bandpass of 0–134 Hz. Data were off-line re-
referenced to computed mastoids. Off-line, EEG and EOG
activity was filtered with a bandpass of 0.10–30 Hz (phase shift-
free Butterworth filters; 24 dB/octave slope). Data were segment-
ed in epochs of 1 second (200 ms before and 800 ms after
response or stimulus presentations). After ocular correction [48]
epochs including an EEG signal exceeding 675 mV were excluded
from the average. The mean 200 ms pre-response or pre-stimulus
period served as baseline. After baseline correction, average ERP
waves were calculated for artifact-free trials at each scalp site for
correct and incorrect responses separately. Segments with
incorrect responses (miss for GO trials or false alarm for NoGo
trials) were excluded from EEG analyses. The N2 was defined as
the most negative value within the 200–300 ms time interval after
stimulus onset and was studied at a cluster of frontocentral
electrodes, including Fz, FC1, FC2, FCz and Cz [49]. The P3 was
defined as the most positive value within the 300–500 ms time
interval after stimulus onset. The P3 was studied at a cluster of
central electrodes, including FCz, Cz, C3, C4 and CPz [49]. The
mean number of analyzable Go and NoGo epochs for smoking
pictures was 248.50 and 56.00 respectively and 250.57 and 55.26
for non-smoking pictures. One non-smoker was excluded from
ERP analyses because of less than 10 artifact free ERP epochs in at
least one of the task conditions. This participant was included in all
remaining data analyses.
Statistical analysis
The difference in self-reported craving before and after task
performance was analyzed by means of a paired samples t-test.
Repeated Measures Analyses of Variance (RM-ANOVA; with
Greenhouse-Geisser adjusted p-values) were applied to analyze
behavioral outcomes of performance on the Go/NoGo task, as
well as ERP indices of response inhibition. The between-subjects
factor in all RM-ANOVA’s was Group (smokers versus non-
smokers). Two-level within-subject factors were of interest, namely
(a) Inhibition (Go versus NoGo), and (b) Picture (smoking versus
non-smoking pictures). A Group6Inhibition6Picture RM-AN-
OVA was employed to analyze the behavioral accuracy during the
Go/NoGo task, and a Group6Picture RM-ANOVA was chosen
to analyze reaction times in Go trials. Electrode (Fz, FC1, FC2,
FCz, Cz for N2 and FCz, Cz, C3, C4, and CPz for P3) was
included as a five-level within subject factor in the ERP analyses.
That is, a Group6Inhibition6Picture6Electrode RM-ANOVA
was performed for the ERP analyses. Post-hoc tests for interactions
were performed only for interactions including the between subject
factor Group. A Bonferroni correction for multiple comparisons
was applied in all post-hoc analyses. Finally,Spearman correlation
coefficients were calculated for the number of cigarettes per day on
the one hand and NoGo accuracy rates and average cluster peaks
across all electrodes for the NoGo N2 and P3 on the other hand.
Results
Breath CO levels and questionnaires
In line with expectancies, smokers had a higher breath
concentration of carbon monoxide (CO; in parts per million,
M=12.89, SD=7.15) as compared to non-smoking controls
(M=1.15, SD=1.04), t(37) = 7.27, p,0.001. Subjective craving
in smokers increased significantly from the start (M=37.53,
SD=10.02) to the end (M=46.05, SD=9.79) of the experiment,
t(18) = 4.35, p,.001.
Figure 1. Example of a Go and NoGo trial combined with smoking neutral pictures in the smoking cue Go/NoGo task.
doi:10.1371/journal.pone.0018898.g001
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Behavioral data
The accuracy rates for both the smoking and non-smoking
group on the smoking-related Go/NoGo task are displayed in
Figure 2.A robust main effect of Inhibition was found,
F(1,37) = 184.55, p,0.001 showing that participants were less
accurate on NoGo trials (69.63% versus 96.86% respectively).
There was also a main effect for Group, F(1,37) = 4.12, p= .05,
which indicated that overall task performance was less accurate in
smokers than in non-smoking controls (80.47% 86.03%, respec-
tively). A trend to significance was found for the Group6Inhibition
interaction, F(1,37) = 3.27, p=0.08. Post-hoc t-tests revealed that,
particularly on NoGo trials, smokers performed less accurate than
non-smoking controls (p=0.05; 65.05% versus. 74.23%), whereas
there was no difference on accuracy between the groups for Go
trials. No main or interaction effects of Picture were found for
accuracy of responding. We additionally performed two seperate
RM-ANOVA’s for Go and NoGo accuracy scores because of
differences in the distibution for Go and NoGo accuracy which
may lead to subsequent differences in the magnitude of effects for
Go and NoGo accuracy. Results showed the same pattern as the
combined analysis. A main effect for Group was found for NoGo
accuracy. F(1,37) = 4.02, p=0.05 confirming that smokers were
less accurate than controls on NoGo trials. No difference on
accuracy between groups was found for Go trials. No main or
interaction effects of Picture were found for accuracy of
responding in either NoGo or Go trials.
With regard to the reaction time data, a main effect of Picture
was found, F(1,37) = 6.28, p,.05 indicating that participants
generally responded faster to smoking-related Go trials than to
neutral Go trials (M=259.69 ms versusM=261.89 ms). No other
significant effects were found for reaction times. No significant
correlations were found between the number of cigarettes smoked
per day and accuracy rates for NoGo trials.
N2 amplitudes
The N2 amplitude for smoking-related and neutral pictures in
both groups is displayed in Figure 3. In line with the hypotheses, a
robust main effect was found for Inhibition, F(1,36) = 36.83,
p,.001 on the N2 component at the frontocentral electrode
cluster. This result demonstrates that N2 amplitudes were
generally larger for NoGo trials than for Go trials. Importantly,
a Group6Inhibition interaction effect was found, F(1,36) = 6.31,
p= .017. Post-hoc t-tests indicated that only on NoGo trials the N2
was significantly reduced in smokers as compared to non-smoking
controls (p= .046), whereas there were no between-group
differences on N2 amplitude in response to Go trials. Furthermore,
a main effect for electrode was found, F(4,144) = 25.67, p,.001.
No Picture-related main or interaction effects were found for the
N2 component. No significant correlations were found between
the number of cigarettes smoked per day and the cluster combined
N2 peak amplitudes for NoGo trials.
P3 amplitudes
Figure 4 shows the P3 amplitudes for smoking and neutral
pictures in both groups. As expected for the P3 at the central
electrode cluster, a robust main effect was found for Inhibition,
F(1,36) = 138.85, p,.001. This result indicates that the P3 peaks
were generally larger for NoGo trials than for Go trials.
Furthermore, a main effect for electrode was found,
F(4,144) = 18.73, p,.001. No other significant main or interaction
effects including Group were found for P3 amplitude. No
significant correlations were found between the number of
cigarettes smoked per day and the cluster combined P3 peak
amplitudes for NoGo trials.
Discussion
The main purpose of the present study was to investigate
differences in response inhibition on a behavioral as well as on an
electrophysiological level using a smoking-modified Go/NoGo
paradigm in combination with the recording of event-related
potentials. Consistent with the notion that the N2 reflects an
inhibitory process, the N2 was significantly enhanced on NoGo
trials as compared to Go trials. More importantly and in line with
our primary hypothesis differences between smokers and non-
smokers were found on both behavioral and electrophysiological
indices of response inhibition. That is, performance on the Go/
NoGo task was generally less accurate in smokers than non-
smokers in such that smokers displayed significantly more
difficulties to inhibit their responses in NoGo trials. This deficit
in general response inhibition was also reflected in reduced N2
amplitudes in NoGo trials in smokers as compared to non-
smokers.
Previous studies on inhibitory control in smokers, which used
behavioral paradigms, such as the Go/NoGo task generally
yielded inconsistent results [13–16]. The difficulty level of the task
of the current study, however, was different than previous studies.
The Go/NoGo task that was used in the present study placed high
demands on inhibition capacities because stimulus presentation
was fast and NoGo trials were infrequent. This is supported by the
fact that 31.4% of the NoGo trials resulted in commission errors in
the current study while this is usually much lower (e.g., 5% percent
in Dinn et al. [14]). In addition, the present study was the very first
to include the N2 component as an additional index of inhibitory
control in smokers. The NoGo N2 amplitude is an index of
response inhibition which is believed to be more sensitive than
behavioral outcomes in the Go/NoGo paradigm [50,51]. The fact
that reduced inhibitory control was found in behavioral accuracy
as well on the N2 component of the ERP provides support for the
hypothesis that there is a general shortcoming in response
inhibition in smokers relative to non-smokers. It must be noted,
however, that the current study design does not allow drawing
conclusions on causality. It may be that reduced inhibitory control
is the result of prolonged nicotine dependence, for example via
abnormalities in the dopamine system, or that reduced inhibitory
control is a predisposition to start smoking. The latter interpre-
tation may be more convincing according to the results of the
current study because of the lack of association between measures
Figure 2. Accuracy rates in smokers and non-smoking controls
on the smoking cue Go/NoGo task.
doi:10.1371/journal.pone.0018898.g002
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of inhibitory control and nicotine exposure (i.e. the number of
cigarettes smoked per day). This association could be expected if
reduced inhibitory control is the result of a modulation of brain
systems by nicotine intake.
With regard to P3, enlarged amplitudes in NoGo trials than
Go trials were observed confirming that, like the N2 amplitude,
P3 amplitude is related to response inhibition processes.
However, contrary to N2 and behavioral accuracy, no differences
between groups were found in NoGo P3 amplitude. It has been
suggested that, whereas the NoGo N2 might be related to an
early stage of the response inhibition process, the NoGo P3 might
reflect a later stage of the inhibition process that is closely related
to the actual inhibition of the motor system [26]. Accordingly, the
present study results suggest that the reduced inhibitory control in
smokers reflect a dysfunctional activation of inhibitory processes
at an early stage of cortical processing while later stages of the
inhibition process may be intact. This is in line with findings in
heroin dependent patients [32] but in contrast to previous
findings in alcohol dependent patients [31], ecstasy polydrug
users [34] and smokers [33]. Unfortunately, the latter studies did
not investigate N2 amplitudes making complete comparisons with
the present study impossible. Furthermore, the diverse charac-
teristics of the Go/NoGo paradigms used in these studies might
have contributed to differential findings [31]. For example, the
probability of NoGo trials, and thereby the demand on response
inhibition capacities, varies largely among these ERP studies just
as in the studies investigating behavioral accuracy. Furthermore,
it is not clear whether previous studies separated successful and
unsuccessful trials in examining P3 amplitudes which is important
because P3 amplitudes are influenced by inhibition success or
failure [26].
The present study was the first that investigated not only general
response inhibition in smokers, but specific response inhibition
towards smoking-related stimuli as well. Several authors suggest
that inhibitory control in substance-dependent individuals is
especially reduced when exposed to drug-related cues and that
this eventually may contribute to compulsive cue-elicited drug
intake [3,7,52]. The findings in the current study could not
confirm that reduced inhibitory control in smokers is more
pronounced in the presence of smoking cues. In fact, the current
findings show that inhibitory control is reduced in smokers during
smoking cue exposure and during neutral affective conditions
suggestingthat these deficits found in smokers are of a more
general category, which may be in favor of the diagnostic value
and theoretical importance of the Go NoGo task paradigm.
Furthermore, these results imply that decreased inhibitory control
may not only influence smoking related behavior but also other
impulsive and possibly maladaptive behaviors. This idea is
supported by the high proportion of smokers in, for example,
conduct disorder [53] and problem gambling [6].However, the
influence of drug cue-exposure on levels of inhibitory control
should be further investigated in future studies. Possibly, the
overall reduced inhibitory capacity of smokers, which was
observed in the present study, reflects a general effect of nicotine
craving. That is, controlling the craving elicited by the smoking-
related pictures during the task might have required cognitive
resources [54] which might have resulted in an overall reduced
inhibitory capacity. In the present study, smokers reported
significantly increased craving after task performance as compared
to before showing that smokers had to deal with increasing levels
of craving evoked by the smoking-related pictures used in the Go/
NoGo task. One way to examine if craving has a general effect on
Figure 3. Grand-average stimulus-locked waveforms for neutral and smoking pictures at Fz for correct Go and NoGo trials in
smokers and non-smoking controls.
doi:10.1371/journal.pone.0018898.g003
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performance of the smoking-modified Go/NoGo paradigm, could
be to present the stimuli to participants in a blocked design, with
one block of neutral pictures being presented first, followed by a
block of smoking-related pictures to measure response inhibition
under low and high conditions of craving separately.
In conclusion, results of the current study showed reduced
inhibitory control in smokers both at behavioral and physiological
measures. Decreased N2 amplitudes for NoGo trials were
accompanied by reduced accuracy for NoGo trials. However,
the hypothesis that reduced response inhibition would be more
pronounced for smoking related cues could not be confirmed.
These results suggest that smokers have difficulties with inhibitory
control, which might be an important factor in the initiation and
continuation of smoking behaviors as well as relapse in smoking
behaviors. These findings can eventually be implemented in
smoking cessation programs.
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